XML 15 R4.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Statements of Income and Comprehensive Income (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended
Apr. 01, 2018
Apr. 02, 2017
Revenues $ 23,069 $ 22,035
Cost of Products Sold 15,787 15,145
Gross Profit 7,282 6,890
Operating Expenses:    
Research and Development 1,101 1,138
Selling, General and Administrative 3,825 3,911
Total Operating Expenses 4,926 5,049
Operating Income 2,356 1,841
Other Expenses:    
Interest and Financing Expense (33) (68)
Miscellaneous (100) (25)
Total Other Expenses (133) (93)
Income Before Income Tax Provision 2,223 1,748
Tax Provision (55) (87)
Net Income 2,168 1,661
Non-Controlling Interest (17) (6)
Net Income Attributable to Ultralife Corporation 2,151 1,655
Other Comprehensive Income:    
Foreign Currency Translation Adjustments 752 259
Comprehensive Income Attributable to Ultralife Corporation $ 2,903 $ 1,914
Net Income Per Share Attributable to Ultralife Common Shareholders – Basic (in dollars per share) $ 0.14 $ 0.11
Net Income Per Share Attributable to Ultralife Common Shareholders – Diluted (in dollars per share) $ 0.13 $ 0.11
Weighted Average Shares Outstanding – Basic (in shares) 15,704 15,412
Potential Common Shares (in shares) 498 244
Weighted Average Shares Outstanding – Diluted (in shares) 16,202 15,656